NeOnc Technologies Holdings is trading at $3.00, down 5.36% in after-hours trading; no verified November 4 company-specific catalyst explaining the decline was found.
- The latest identified company news was a November 2 announcement of planned NEO100 and NEO212 presentations at the November 13 Society for Neuro-Oncology meeting.
- That news predates the move and does not establish a cause.
- Broad U.S. indexes rose on November 4, unlike the stock. Available evidence leaves the reason unclear; the supplied price context is the basis for the after-hours move.